ABSTRACT
Marcadores sorológicos são rotineiramente utilizados na prática clínica para o estadiamento de linfomas e para a determinação de seu prognóstico em humanos. No entanto, pouco se sabe sobre sua utilização em cães, mesmo os linfomas sendo neoplasias com alta prevalência nessa espécie. No presente estudo, as concentrações séricas do receptor solúvel de interleucina-2 (sIL-2R) e do antígeno do câncer 125 (CA 125) foram mensurados em 10 cães saudáveis e em 15 cães com linfoma cutâneo, utilizando-se o kit ELISA canino e a leitura em um Stat Fax modelo 2100 (sIL-2R), bem como o kit ELISA humano e a leitura pelo ELISYS UNO humano (CA 125). Os resultados mostraram que não houve diferença significativa (P<0,05) nas concentrações dos marcadores entre os grupos. Além disso, os resultados não apontaram significância clínica no estadiamento tumoral e estabelecimento do prognóstico em cães diagnosticados com linfoma cutâneo.(AU)
Subject(s)
Animals , Dogs , Biomarkers/blood , Receptors, Interleukin-2/blood , CA-125 Antigen/blood , Lymphoma/veterinary , Prognosis , Skin Neoplasms/veterinaryABSTRACT
OBJECTIVE@#To investigate the clinical value of expression level of interleukin-2 receptor (IL-2R) and interleukin-8 (IL-8) in the fever patients with hematological malignancies.@*METHODS@#A total of 121 inpatients in the First Affiliated Hospital of Anhui Medical University from April 2018 to October 2019 were enrolled in this study. The patients were separated into infection group (61 cases) and non-infection group (60 cases). In the meantime, 40 healthy people without fever or infection in the hospital for physical examination were set as matched group. C-reactive protein (CRP), procalcitonin (PCT), and cytokines were detected in all the patients with fever after admission and infection control. While, blood samples were taken from healthy people during physical examination.@*RESULTS@#The expression levels of IL-2R in infection group were higher than those in the control group (P<0.001), and the level of serum IL-2R in infection group was also higher than that in the non-infection group (P<0.05). Based on Spearman analysis, in patients with malignant hematologic disease, serum IL-2R level was positively correlated with CRP (r=0.557, P<0.001) and IL-8 (r=0.479, P<0.001), and IL-8 level was positively correlated with CRP (r=0.318, P<0.001). Compared with the non-infection group, the area under the curve (AUC) for the level of CRP, PCT, and IL-2R of the infection group was 0.714 (95%CI: 0.623-0.806), 0.765 (95%CI: 0.680-0.851), and 0.761 (95%CI: 0.686-0.836), the sensitivity was 0.705, 0.852, and 0.705, and the specificity was 0.717, 0.70, and 0.60, respectively. While, AUC of CRP+PCT, CRP+IL-2R, PCT+IL-2R, and CRP+PCT+IL-2R was 0.789 (95%CI: 0.712-0.866), 0.702 (95%CI: 0.623-0.782), 0.757 (95%CI: 0.677-0.838), and 0.789 (95%CI: 0.712-0.866), the sensitivity was 0.738, 0.934, 0.705, and 0.738, and the specificity was 0.840, 0.470, 0.810, and 0.840, respectively.@*CONCLUSION@#CRP, PCT, IL-2R, and IL-8 are useful parameters for diagnosis of the infectious fever in patients with hematological malignancies, which provides the basis of initial diagnosis and rational use of antibioties for clinician.
Subject(s)
Humans , Biomarkers , C-Reactive Protein , Calcitonin , Calcitonin Gene-Related Peptide , Hematologic Neoplasms , Interleukin-8 , Protein Precursors , Receptors, Interleukin-2 , SepsisABSTRACT
El síndrome de activación macrofágica (SAM) presenta criterios clínicos y de laboratorio establecidos. Presentamos el caso de un adolescente varón con debut de Lupus eritematoso generalizado pediátrico grave, donde su manifestación principal fue un SAM y el receptor de interleucina 2 soluble en suero (IL-2rs) o CD25 soluble (CD25s) aumentado resultó clave en la confirmación diagnóstica, en el tratamiento y pronóstico de su enfermedad. Sin embargo, este receptor de citocinas no se mide habitualmente en la práctica clínica.
Macrophage activation syndrome (MAS) presents established clinical and laboratory criteria. We present the case of a male adolescent with the onset of severe pediatric systemic Lupus erythematosus, manifested mainly by MAS and how a laboratory marker, serum soluble interleukin-2 receptor (IL-2rs) or altered soluble CD25(CD25s), played a key role in treatment and prognosis of the disease. However, this cytokine receptor is rarely measured in clinical practice.
Subject(s)
Humans , Male , Child , Lymphohistiocytosis, Hemophagocytic/diagnosis , Lymphohistiocytosis, Hemophagocytic/therapy , Macrophage Activation Syndrome/diagnosis , Macrophage Activation Syndrome/therapy , Thorax/diagnostic imaging , Radiography, Thoracic/methods , Receptors, Interleukin-2 , Macrophage Activation Syndrome/pathology , Lupus Erythematosus, SystemicABSTRACT
OBJECTIVE: Schizophrenia is a disabling disorder of unknown aetiology, lacking definite diagnostic method and cure. A reliable biological marker of schizophrenia is highly demanded, for which traceable immune mediators in blood could be promising candidates. We aimed to gather the best findings of neuroinflammatory markers for first-episode psychosis (FEP). METHODS: We performed an extensive narrative review of online literature on inflammation-related markers found in human FEP patients only. RESULTS: Changes to cytokine levels have been increasingly reported in schizophrenia. The peripheral levels of IL-1 (or its receptor antagonist), soluble IL-2 receptor, IL-4, IL-6, IL-8, and TNF-α have been frequently reported as increased in FEP, in a suggestive continuum from high-risk stages for psychosis. Microglia and astrocytes establish the link between this immune signalling and the synthesis of noxious tryptophan catabolism products, that cause structural damage and directly hamper normal neurotransmission. Amongst these, only 3-hydroxykynurenine has been consistently described in the blood of FEP patients. CONCLUSION: Peripheral molecules stemming from brain inflammation might provide insightful biomarkers of schizophrenia, as early as FEP or even prodromal phases, although more time- and clinically-adjusted studies are essential for their validation.
Subject(s)
Humans , Astrocytes , Biomarkers , Encephalitis , Interleukin-1 , Interleukin-4 , Interleukin-6 , Interleukin-8 , Metabolism , Methods , Microglia , Polytetrafluoroethylene , Psychotic Disorders , Receptors, Interleukin-2 , Schizophrenia , Synaptic Transmission , TryptophanABSTRACT
Thyroid diseases, including autoimmune thyroid diseases and thyroid cancer, are known to have high heritability. Family and twin studies have indicated that genetics plays a major role in the development of thyroid diseases. Thyroid function, represented by thyroid stimulating hormone (TSH) and free thyroxine (T4), is also known to be partly genetically determined. Before the era of genome-wide association studies (GWAS), the ability to identify genes responsible for susceptibility to thyroid disease was limited. Over the past decade, GWAS have been used to identify genes involved in many complex diseases, including various phenotypes of the thyroid gland. In GWAS of autoimmune thyroid diseases, many susceptibility loci associated with autoimmunity (human leukocyte antigen [HLA], protein tyrosine phosphatase, non-receptor type 22 [PTPN22], cytotoxic T-lymphocyte associated protein 4 [CTLA4], and interleukin 2 receptor subunit alpha [IL2RA]) or thyroid-specific genes (thyroid stimulating hormone receptor [TSHR] and forkhead box E1 [FOXE1]) have been identified. Regarding thyroid function, many susceptibility loci for levels of TSH and free T4 have been identified through genome-wide analyses. In GWAS of differentiated thyroid cancer, associations at FOXE1, MAP3K12 binding inhibitory protein 1 (MBIP)-NK2 homeobox 1 (NKX2-1), disrupted in renal carcinoma 3 (DIRC3), neuregulin 1 (NRG1), and pecanex-like 2 (PCNXL2) have been commonly identified in people of European and Korean ancestry, and many other susceptibility loci have been found in specific populations. Through GWAS of various thyroid-related phenotypes, many susceptibility loci have been found, providing insights into the pathogenesis of thyroid diseases and disease co-clustering within families and individuals.
Subject(s)
Humans , Autoimmunity , Genes, Homeobox , Genetics , Genome-Wide Association Study , Graves Disease , Hashimoto Disease , Leukocytes , Neuregulin-1 , Phenotype , Protein Tyrosine Phosphatase, Non-Receptor Type 22 , Receptors, Interleukin-2 , T-Lymphocytes, Cytotoxic , Thyroid Diseases , Thyroid Gland , Thyroid Neoplasms , Thyrotropin , ThyroxineABSTRACT
OBJECTIVE@#To study the expression of Interleukin2 (IL-2) signaling pathway related factors and Treg cell in nasal tissue of nasal polyps, so that to investigate the possible mechanism of IL-2 signaling pathway in the progress of nasal polyps and the correlation between IL-2 pathway and Treg cell.@*METHOD@#Thirty patients were enrolled for study, including the patients with nasal polyps and those with only deviated nasal septum as normal control. The nasal polyps tissue and the turbinate mucosa of the patients were collected during surgery. The expression levels of IL-2 and IL-2R were measured by means of ELISA. The level of pSTAT5 was evaluated by Western blot. We measured the level of Foxp3 mRNA in the tissue by real-time PCR, and the proportion of Treg cells was evaluated by flow cytometry. Finally. we analyzed the correlation between IL-2 pathway related factors and Treg cells in nasal polyps.@*RESULT@#The expression levels of IL-2. IL-2R and pSTAT5 were significantly decreased in the nasal polyps compared with normal control (P < 0.05), and the level of Foxp3 mRNA and proportion of Treg cells in patients with nasal polyps were significantly lower than in normal control (P < 0.05). Moreover, there was positive correlation between the levels of IL-2 pathway related factors and the levels of Foxp3 mRNA and Treg cells proportion in nasal polyps.@*CONCLUSION@#The activated state of IL-2 signaling pathway got changed in nasal polyps tissue, the level of which was positively correlated with the expression of Treg cells, indicating that the IL-2 signaling pathway may play a crucial role in the development of nasal polyps, and the decreased level of Treg cells in nasal polyps may result from the downregulation of IL-2 signaling pathway.
Subject(s)
Adult , Female , Humans , Male , Middle Aged , Forkhead Transcription Factors , Metabolism , Interleukin-2 , Metabolism , Nasal Polyps , Metabolism , Receptors, Interleukin-2 , Metabolism , STAT5 Transcription Factor , Metabolism , Signal Transduction , T-Lymphocytes, Regulatory , Cell BiologyABSTRACT
<p><b>OBJECTIVE</b>To analyze the correlation between the pneumoconiosis severity and the cytokines levels in serum and bronchoalveolar lavage fluid (BALF) or blood T cell subsets.</p><p><b>METHODS</b>The subjects were divided into five groups: control group (6 cases), group exposed to dusts (6 cases) and 3 pneumoconiosis groups (36 in stage I, 12 in stage II and 10 in stage III). ELISA was used to detect IL-6, sIL-2R and TNF-α levels in serum and BALF. The subsets of blood T cells were classified by flow cytometer.</p><p><b>RESULTS</b>As compared with control group and group exposed to dusts, the levels of serum IL-6 and sIL-2R in patients with II or III stages significantly increased, which were positively correlated with pneumoconiosis stages (r(1) = 0.74, r(2) = 0.81, P < 0.05). The level of serum TNF-α significantly decreased in patients with III stages, as compared with control group and group exposed to dusts. There was a negative correlation between serum TNF-α level and pneumoconiosis severity (r = -0.58, P < 0.05). There was a positive correlation between the levels of IL-6, sIL-2R and TNF-α in BALF and the levels of IL-6, sIL-2R and TNF-α in serum (r(1) = 0.77, r(2) = 0.96 and r(3) = 0.88, P < 0.05). The proportion of CD(4)(+)T cells and the ratio of CD(4)(+)/CD(8)(+) decreased dramatically in patients with II and III stages. But there was no correlation between these values and disease severity.</p><p><b>CONCLUSION</b>The immune function in Th cell was inhibited. The levels of IL-6, sIL-2R and TNF-α in serum and BALF were associated with the severity of pneumoconiosis.</p>
Subject(s)
Female , Humans , Male , Bronchoalveolar Lavage Fluid , Allergy and Immunology , CD4-CD8 Ratio , Case-Control Studies , Cytokines , Blood , Metabolism , Interleukin-6 , Blood , Metabolism , Pneumoconiosis , Allergy and Immunology , Metabolism , Pathology , Receptors, Interleukin-2 , Blood , Metabolism , T-Lymphocyte Subsets , Tumor Necrosis Factor-alpha , Blood , MetabolismABSTRACT
Hepatitis C virus [HCV] is considered the most common etiology of chronic liver disease in Egypt. It infects immune cells such as B and T lymphocytes, altering their normal functions. Thus liver damage is thought to be the result of these factors that affect the immune response to viral antigens. This study aimed to determine the role of serum soluble interleukin-2 receptor [sIL-2R] and cellular interleukin-2 receptor in the hepatitis C virus disease, and to determine whether other cellular markers have any role to play in that process. In addition to assess the relationship between different diagnostic tools for estimating HCV activity, particularly measurement of serum viral load by branched DNA technology. Levels of sIL-2R were measured by ELISA in the sera of 35 chronic liver disease [CLD] patients, 35 asymptomatic hepatitis C virus carriers [ASC] and 15 healthy subjects negative for HCV markers served as normal controls [NC]. Also, we studied peripheral blood mono-nuclear cells [PBMNCs] samples from the study groups for the surface expression of CD7, CD19 and CD25. The mean serum sIL-2R levels were significantly elevated in the CLD group compared to ASC and NC groups [P. value <0.001, <0.001 respectively]. Patients with CLD showed significant increase in both CD7[+]/CD25[+] PBMNCs [represent mostly active T lymphocytes] and CD19[+]/CD25[+] PBMNCs [represent mostly active B lymphocytes] than other groups. Both patients groups showed decrease in both CD7[+]/CD25[+] PBMNCs [represent mostly T lymphocytes] and CD19[+]/CD25[+] PBMNCs [represent mostly B lymphocytes] than normal control group. Soluble interleukin -2 receptors [sIL-2R] concentration may be a useful non-invasive surrogate marker of disease activity in HCV infection; high levels of sIL-2R are related to activity of the disease rather than to virus replication
Subject(s)
Humans , Male , Female , Receptors, Interleukin-2/blood , Liver Diseases , Biomarkers , Disease ProgressionABSTRACT
<p><b>OBJECTIVE</b>To explore the effects of electroacupuncture on exercise-induced immunosuppression in rats and its mechanism.</p><p><b>METHODS</b>Sports immunosuppressive model was established successfully by the rats were conducted high intensity swimming training 150 min/day, 6 days/wk for 8 weeks in this study. Forty-three SD rats were randomly divided into a control group (group A, n = 10), a high intensity swimming training group (group B, n = 17), and a high intensity plus electroacupuncture group (group C, n = 16). Group A did not receive any intervention. Group B was conducted 150 min/day, 6 days/wk swimming training for 8 weeks. Group C was treated with electroacupuncture at "Baihui" (GV 20), "Guanyuan" (CV 4) and "Zusanli" (ST 36) after every exercise-time from the second week, once each day for 7 weeks. The changes of the rats' weight, gamma-interferon (gamma-IFN), interleukin-2 (IL-2), solubility IL-2 receptor (SIL-2R) and nature killer cell (NKC) were detected.</p><p><b>RESULTS</b>(1) Compared with group A, gamma-IFN and IL-2 in group B were significantly decreased (P < 0.01, P < 0.05), and NKC in group C was significantly increased (P < 0.01). Meanwhile, gamma-IFN and NKC in group C were both significantly higher than that in group B (P < 0.05, P < 0.01). (2) Compared with group A, the weight of the rats in group B and group C were significantly decreased (both P < 0.01), but SIL-2R in group B was significantly increased (P < 0.05). The weight of the rats in group C was significantly higher than that in group B (P < 0.05) and SIL-2R in group C was significantly lower than that in group B (P < 0.01).</p><p><b>CONCLUSION</b>Lasting gravis exercise stress does decrease the immune function in rats and is even inhibited significantly, but electroacupuncture can up-regulate the exercise-induced immunosuppression.</p>
Subject(s)
Animals , Male , Rats , Electroacupuncture , Interferon-gamma , Blood , Physiology , Interleukin-2 , Blood , Physiology , Killer Cells, Natural , Allergy and Immunology , Physical Conditioning, Animal , Rats, Sprague-Dawley , Receptors, Interleukin-2 , Blood , Physiology , Stress, Physiological , Allergy and ImmunologyABSTRACT
Hepatitis C virus [HCV] is a major cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma worldwide. A strong Thl response seems to be associated with viral clearance. It is generally accepted that T cell activation is characterized by the synthesis and secretion of interleukin-2 and by the expression of Interleukin-2 receptors [IL-2R] on the cell surface of immune cells. The aim of this study is to determine the evolution of soluble IL-2 receptors [sIL2-R], as an indicator of activation of T cells in HCV patients treated with ribavirin and pegylated interferon and its correlation with outcome of therapy. 53 naive [previously not treated] chronic HCV patients eligible for criteria of therapy according to the international guidelines were recruited. Pegylated interferon alpha-2a [IFNalpha-2a] was used subcutaneously once a week for 48 weeks. Ribavirin tablets in a dose of 13mg/kg were given daily in 2 divided doses Liver function and complete blood picture were monitored weekly for the first month and then monthly in the course of administration of therapy. HCV-RNA was monitored every 3 month. Sera were collected at different time point before and during therapy and tested for level of soluble IL2-R using ELISA techniques. Prior to therapy, mean serum soluble IL-2R level was significantly higher in patients with HCV as compared to controls [3709.05 +/- 291.4 pg/ml versus 1770.6 pg/ml +/- 220.3, p<0.01]. After end of therapy, patients were retrospectively classified into 2 groups, responders and non-responders. In responders, the level of sIL-2R raised significantly after 4 weeks of therapy as compared to pre-treatment level [4501 +/- 309 pg/ml versus 3550 +/- 291 pg/ml p= 0.01]. In non-responders, however, the difference in serum sIL2R before therapy and after 4 weeks of therapy was non-significant [4021 +/- 567 pg/ml versus 3934 +/- 550 pg/ml p=0.9]. The levels of serum sIL2-R significantly correlated in a linear model with ALT levels before starting the therapy. Monitoring of sIL-2R levels may therefore be of value as an adjunct to the measurement of serum ALT and HCV-RNA in predicting the response to interferon therapy in HCV patients